The tryptophan prenyltransferase ComQ from Bacillus subtilis 168 can prenylate daptomycin at Trp1
The FEBS Journal · 2026-11 · 293 (21) · 6413-6425
DOI: 10.1111/febs.70578 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 02.05.2026. Verfasst von Yanli Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, The Netherlands. Hauptthemen laut MEDLINE: Bacillus subtilis, Daptomycin, Dimethylallyltranstransferase, Tryptophan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
Prenylation is a common natural modification that enhances peptide bioactivity. Identifying prenyltransferases with broad substrate specificity is vital for enabling the modification of diverse compounds. In Bacillus subtilis 168, the tryptophan at Position 3 from the C terminus of the ComX 168 pheromone is farnesylated by ComQ 168 , producing an inducer of natural competence. While ComQ 168 's native substrate, ComX, is a linear peptide, many bioactive cyclic peptides like daptomycin and polymyxin also contain long lipid tails, similar to farnesylated ComX. This study investigates whether ComQ 168 can be used as a synthetic biology tool to farnesylate cyclic antimicrobial peptides. ComQ 168 was cloned from B. subtilis 168, expressed in E. coli , and purified in soluble fusion form. Its ability to farnesylate ComX, which was generated by a ribosomally synthesized and post‐translationally modified peptide (RiPPs) approach, confirmed its activity and proper folding. Remarkably, TF‐ComQ 168 also catalyzed farnesylation of daptomycin in vitro , most likely at the N‐terminal tryptophan residue. To explore substrate recognition, AlphaFold modeling was used to predict the binding pocket of ComQ 168 with both ComX and daptomycin, highlighting a C‐terminal region potentially important for substrate interaction. These insights offer a promising starting point for engineering ComQ 168 variants with expanded substrate scopes. In summary, this work demonstrates for the first time that ComQ 168 , previously known to modify linear peptides, can also farnesylate cyclic peptides—establishing its potential as a versatile tool in the biosynthetic engineering of bioactive compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, The Netherlands.
- Molecular Enzymology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, The Netherlands.
ORCID-Profile: Oscar P Kuipers
Förderung
- China Scholarship Council
Zitieren
APA
Xu, Y., Fürst, M. J. L. J., & Kuipers, O. P. (2026). The tryptophan prenyltransferase ComQ from Bacillus subtilis 168 can prenylate daptomycin at Trp1. The FEBS Journal, 293(21), 6413-6425. https://doi.org/10.1111/febs.70578
Vancouver
Xu Y, Fürst MJLJ, Kuipers OP. The tryptophan prenyltransferase ComQ from Bacillus subtilis 168 can prenylate daptomycin at Trp1. The FEBS Journal. 2026;293(21):6413-6425. doi:10.1111/febs.70578
BibTeX
@article{Xu2026,
author = {Xu, Yanli and Fürst, Maximilian J L J and Kuipers, Oscar P},
title = {The tryptophan prenyltransferase ComQ from Bacillus subtilis 168 can prenylate daptomycin at Trp1},
journal = {The FEBS Journal},
year = {2026},
volume = {293},
number = {21},
pages = {6413--6425},
doi = {10.1111/febs.70578}
}
EUVIMED